These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36112984)

  • 1. Depression, Anxiety, and Their Association to Health-Related Quality of Life in Men Commencing Prostate Cancer Treatment at Tertiary Hospitals in Cape Town, South Africa.
    Irusen H; Fernandez P; Van der Merwe A; Suliman S; Esterhuizen T; Lazarus J; Parkes J; Seedat S
    Cancer Control; 2022; 29():10732748221125561. PubMed ID: 36112984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardising the Assessment of Patient-reported Outcome Measures in Localised Prostate Cancer. A Systematic Review.
    Ratti MM; Gandaglia G; Alleva E; Leardini L; Sisca ES; Derevianko A; Furnari F; Mazzoleni Ferracini S; Beyer K; Moss C; Pellegrino F; Sorce G; Barletta F; Scuderi S; Omar MI; MacLennan S; Williamson PR; Zong J; MacLennan SJ; Mottet N; Cornford P; Aiyegbusi OL; Van Hemelrijck M; N'Dow J; Briganti A;
    Eur Urol Oncol; 2022 Apr; 5(2):153-163. PubMed ID: 34785188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Related Anxiety in Men With Localized Prostate Cancer at Tertiary Hospitals in Cape Town, South Africa.
    Irusen H; Burger H; Fernandez PW; Esterhuizen T; Suliman S; Seedat S
    Cancer Control; 2021; 28():10732748211024239. PubMed ID: 34152224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decisional Conflict is Associated with Treatment Modality and not Disease Knowledge in South African Men with Prostate Cancer: Baseline Results from a Longitudinal Prospective Observational Study.
    Irusen H; Burger H; Fernandez PW; Van der Merwe A; Esterhuizen T; du Plessis DE; Seedat S
    Cancer Control; 2022; 29():10732748221082791. PubMed ID: 35442835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The assessment of health-related quality of life and related factors in Chinese elderly patients undergoing chemotherapy for advanced cancer: a cross-sectional study.
    Li Q; Lin Y; Qiu Y; Gao B; Xu Y
    Eur J Oncol Nurs; 2014 Aug; 18(4):425-35. PubMed ID: 24721179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric evaluation of the EORTC QLQ-PR25 questionnaire in assessing health-related quality of life in prostate cancer survivors: a curate's egg.
    O'Leary E; Drummond FJ; Gavin A; Kinnear H; Sharp L
    Qual Life Res; 2015 Sep; 24(9):2219-30. PubMed ID: 25791618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients.
    Arraras JI; Villafranca E; Arias de la Vega F; Romero P; Rico M; Vila M; Asín G; Chicata V; Domínguez MA; Lainez N; Manterola A; Martínez E; Martínez M
    Clin Transl Oncol; 2009 Mar; 11(3):160-4. PubMed ID: 19293053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life of 1276 elderly patients with prostate cancer, starting treatment with a gonadotropin-releasing hormone agonist: results of a French observational study.
    Lebret T; Culine S; Davin JL; Hennequin C; Mignard JP; Moreau JL; Rossi D; Zerbib M; Mahmoudi A; Latorzeff I
    Aging Male; 2014 Jun; 17(2):87-93. PubMed ID: 24576298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of Quality of Life Subjective Perception by Patients Treated for Prostate Cancer with the EORTC QLQ-C30 Questionnaire and QLQ-PR25 Module.
    Dąbrowska-Bender M; Słoniewski R; Religioni U; Juszczyk G; Słoniewska A; Staniszewska A
    J Cancer Educ; 2017 Sep; 32(3):509-515. PubMed ID: 26614256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life of exposed versus non-exposed androgen deprivation therapy patients with prostate cancer: a cross-sectional study.
    Huang YT; Li CC; Chou YH; Ke HL; Chen CY
    Int J Clin Pharm; 2019 Aug; 41(4):993-1003. PubMed ID: 31240550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.
    Adam S; Koch-Gallenkamp L; Bertram H; Eberle A; Holleczek B; Pritzkuleit R; Waldeyer-Sauerland M; Waldmann A; Zeissig SR; Rohrmann S; Brenner H; Arndt V
    Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13076. PubMed ID: 31050091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study.
    Drummond FJ; Kinnear H; O'Leary E; Donnelly ; Gavin A; Sharp L
    J Cancer Surviv; 2015 Jun; 9(2):361-72. PubMed ID: 25563819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quality of life, anxiety, and depression in Turkish colorectal cancer patients.
    Alacacioglu A; Binicier O; Gungor O; Oztop I; Dirioz M; Yilmaz U
    Support Care Cancer; 2010 Apr; 18(4):417-21. PubMed ID: 19554353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring prostate cancer survivors' self-management behaviours and examining the mechanism effect that links coping and social support to health-related quality of life, anxiety and depression: a prospective longitudinal study.
    Paterson C; Robertson A; Nabi G
    Eur J Oncol Nurs; 2015 Apr; 19(2):120-8. PubMed ID: 25497067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer.
    Rodrigues G; Bezjak A; Osoba D; Catton P; Tsuji D; Taylor D; Warde P
    Qual Life Res; 2004 Sep; 13(7):1235-46. PubMed ID: 15473502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality of life after low-dose rate-brachytherapy for prostate carcinoma - long-term results and literature review on QLQ-C30 and QLQ-PR25 results in published brachytherapy series.
    Buergy D; Schneiberg V; Schaefer J; Welzel G; Trojan L; Bolenz C; Wenz F
    Health Qual Life Outcomes; 2018 Jan; 16(1):21. PubMed ID: 29357874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-cultural application of the Korean version of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire for patients with prostate cancer - EORTC QLQ-PR25.
    Park J; Shin DW; Yun SJ; Park SW; Jeon SS; Kwak C; Kwon TG; Kim HJ; Ahn H
    Oncology; 2013; 85(5):299-305. PubMed ID: 24217330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.
    Wahlgren T; Brandberg Y; Häggarth L; Hellström M; Nilsson S
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):51-9. PubMed ID: 15337539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Income and health-related quality of life among prostate cancer patients over a one-year period after radical prostatectomy: a linear mixed model analysis.
    Klein J; Lüdecke D; Hofreuter-Gätgens K; Fisch M; Graefen M; von dem Knesebeck O
    Qual Life Res; 2017 Sep; 26(9):2363-2373. PubMed ID: 28444552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
    Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
    Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.